Eli Lillys mirikizumab continues to show positive results in Phase II study...
Efficacy and safety results from Eli Lillys Phase II Serenity study in patients with moderate to severe Crohns disease CD...Read More...The post Eli Lilly&8217;s mirikizumab continues to show...
View ArticleGilead and Galapagos to Present Latest Data on Filgotinib at the Annual...
Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions Gilead Sciences Inc. NASDAQ GILD and Galapagos NV Euronext &...
View ArticleGILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL...
Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions Foster City Calif. and Mechelen Belgium; May 29 2019; 22.30 CET Gilead...
View ArticleIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review H1 2019SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
View ArticleMALADIE de CROHN Un probiotique contre le biofilm intestinal
Ce probiotique en instance de brevet pourrait dissiper les biofilms de la maladie de Crohn et affaiblir les communauts intestinales microbiennes persistantes qui peuvent venir aggraver les symptmes de...
View ArticleCrohn's Disease Regional Enteritis Pipeline Review H1 2019 Report Updated...
Crohn's Disease Regional Enteritis Pipeline Review H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crohn's Disease Regional Enteritis Pipeline Review...
View ArticleToll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019 Report...
Toll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019SummaryAccording to the recently published report 'Toll Like Receptor 4 Pipeline Review H1 2019'; Toll Like Receptor 4 hToll or CD284...
View ArticleSFA Therapeutics to Present Human Psoriasis Data for Microbiomebased Drug...
Also Presenting Preclinical Data on Two Additional Pipeline Products SFA Therapeutics Inc. will be presenting human Psoriasis data on its humanmicrobiomebased drug SFA002 as well as preclinical data...
View ArticleStudy Fitbit Devices Could Predict Inflammatory Bowel Disease IBD FlareUps
 Fitbit devices could help predict the flareups of inflammatory bowel disease IBD including Crohns disease and ulcerative colitis according to a new study published in the Journal of Crohn&8217;s...
View ArticleGastrointestinal Disorders Innovative Pipeline Offers Potential for First...
Gastrointestinal Disorders Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac DiseaseSummaryThe burden of disease associated with gastrointestinal disorders is...
View ArticleUS FDA and EMA Accept Applications for Ozanimod for the Treatment of...
Celgene Corporation NASDAQCELG today announced that the U.S. Food and Drug Administration FDA has accepted for review the New Drug Application for ozanimod for the treatment of people with relapsing...
View ArticleInflammatory bowel disease patients have higher health costs
Reuters Health People with inflammatory bowel disease either Crohn's disease or ulcerative colitis may incur health costs more than three times higher than individuals without these conditions a U.S....
View ArticleNovel Diet Eases Crohns in Kids
MedPage Today Outpaced exclusive enteral nutrition for tolerance and efficacy
View ArticleRedHill Biopharma Receives Allowance for New U.S. ...
The new patent expands the robust patent portfolio covering RHB104 and RHB204ÂRedHill plans to initiate a pivotal Phase 3 study with RHB204 for the treatment of pulmonary nontuberculous mycobacteria...
View ArticleHuman medicines European public assessment report EPAR Flixabi infliximab...
Human medicines European public assessment report EPAR Flixabi infliximab Spondylitis AnkylosingArthritis RheumatoidCrohn DiseaseColitis UlcerativeArthritis PsoriaticPsoriasis Date of authorisation...
View ArticleTheravance Biopharma Inc TBPH Financial and Strategic SWOT Analysis Review...
Theravance Biopharma Inc TBPH Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleHuman medicines European public assessment report EPAR Zessly infliximab...
Human medicines European public assessment report EPAR Zessly infliximab Arthritis PsoriaticPsoriasisCrohn DiseaseArthritis RheumatoidColitis UlcerativeSpondylitis Ankylosing Date of authorisation...
View ArticleJanssen presents new realworld evidence at the Annual European Congress of...
The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data this week from PsABio its ongoing realworld study of nearly 1000 people with psoriatic arthritis who have started...
View Article